Blood pressure reducing medications containing valsartam, an active ingredient produced by China's Zhejiang Huahai Pharmaceuticals, are being recalled in Lithuania as they may contain impurities capable of causing cancer.
© DELFI / Karolina Pansevič

Žydrūnas Martinėnas, deputy director of Lithuania's State Medicines Control Agency, told BNS Lithuania that the potential risk of the identified impurities is being assessed by the European Medicines Agency.

In his words, there are market alternatives with the same active ingredient to the recalled medications.

"New medications should be prescribed by the doctor," Martinėnas told BNS Lithuania.

The medications might have been contaminated with impurities during the manufacturing process, the Lithuania's State Medicines Control Agency said.

BNS
It is prohibited to copy and republish the text of this publication without a written permission from UAB „BNS“.

Lithuanian-born American artist buried in Semeniskes

Jonas Mekas , a Lithuanian-born American artist, poet and filmmaker , often called the godfather...

Lithuanian animation returns to "Annecy"

After a two-year break, Lithuanians return to the Annecy International Animation Film Festival...

Success of HBO’s Chernobyl puts Vilnius in spotlight as prime location for filming

Tax incentive, welcoming approach by the government, and big talent pool made Vilnius an attractive...

Promising year for Lithuanian animation

In 2017-2019, the Lithuanian film industry has experienced remarkable growth. As a result,...

Chernobyl in Kaunas: revisiting the shooting locations

As all of the five episodes have already been broadcast and the holiday season has started, here’s a...